These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

791 related items for PubMed ID: 27506704

  • 1. The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
    Reddy DS.
    Clin Pharmacol Ther; 2017 Feb; 101(2):182-184. PubMed ID: 27506704
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cannabis and Endocannabinoid Signaling in Epilepsy.
    Katona I.
    Handb Exp Pharmacol; 2015 Feb; 231():285-316. PubMed ID: 26408165
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V, Reddy DS.
    Adv Exp Med Biol; 2021 Feb; 1264():93-110. PubMed ID: 33332006
    [Abstract] [Full Text] [Related]

  • 6. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA, Zhou R, Jacobson C, Weng J, Cheng E, Lay J, Hung P, Lerner JT, Sankar R.
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [Abstract] [Full Text] [Related]

  • 7. Pharmacology of cannabinoids in the treatment of epilepsy.
    Gaston TE, Friedman D.
    Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
    [Abstract] [Full Text] [Related]

  • 8. Marijuana Use in Epilepsy: The Myth and the Reality.
    Detyniecki K, Hirsch L.
    Curr Neurol Neurosci Rep; 2015 Oct; 15(10):65. PubMed ID: 26299273
    [Abstract] [Full Text] [Related]

  • 9. Cannabinoid therapy in epilepsy.
    Billakota S, Devinsky O, Marsh E.
    Curr Opin Neurol; 2019 Apr; 32(2):220-226. PubMed ID: 30676535
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC, Patra PH, Whalley BJ.
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [Abstract] [Full Text] [Related]

  • 11. The case for assessing cannabidiol in epilepsy.
    Cilio MR, Thiele EA, Devinsky O.
    Epilepsia; 2014 Jun; 55(6):787-90. PubMed ID: 24854434
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS.
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [Abstract] [Full Text] [Related]

  • 13. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
    Szaflarski JP, Bebin EM.
    Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
    [Abstract] [Full Text] [Related]

  • 14. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D.
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).
    Klein BD, Jacobson CA, Metcalf CS, Smith MD, Wilcox KS, Hampson AJ, Kehne JH.
    Neurochem Res; 2017 Jul; 42(7):1939-1948. PubMed ID: 28478594
    [Abstract] [Full Text] [Related]

  • 16. Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials.
    Silvestro S, Mammana S, Cavalli E, Bramanti P, Mazzon E.
    Molecules; 2019 Apr 12; 24(8):. PubMed ID: 31013866
    [Abstract] [Full Text] [Related]

  • 17. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK, Gloss D, Devinsky O.
    Epilepsy Behav; 2017 May 12; 70(Pt B):341-348. PubMed ID: 28188044
    [Abstract] [Full Text] [Related]

  • 18. The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next.
    Rubin R.
    JAMA; 2018 Sep 25; 320(12):1227-1229. PubMed ID: 30193358
    [No Abstract] [Full Text] [Related]

  • 19. The case for medical marijuana in epilepsy.
    Maa E, Figi P.
    Epilepsia; 2014 Jun 25; 55(6):783-6. PubMed ID: 24854149
    [Abstract] [Full Text] [Related]

  • 20. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy.
    Pietrafusa N, Ferretti A, Trivisano M, de Palma L, Calabrese C, Carfì Pavia G, Tondo I, Cappelletti S, Vigevano F, Specchio N.
    Paediatr Drugs; 2019 Aug 25; 21(4):283-290. PubMed ID: 31179531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.